Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein cysteine residues are characterized by a reactive sulfhydryl (thiol) group that plays a pivotal role in protein structure, function, and regulation. They are essential for the formation of disulfide bridges, which stabilize the tertiary and quaternary structures of many extracellular and secreted proteins (Source: UniProt). Cysteines also function as potent nucleophiles in the catalytic sites of various enzymes, such as proteases and phosphatases, and act as ligands for metal ion coordination in zinc finger proteins (Source: PubMed, PMID: 23510398). Furthermore, the thiol group is highly sensitive to the cellular redox environment, undergoing reversible modifications like S-nitrosylation and S-glutathionylation that serve as key signaling mechanisms (Source: PubMed, PMID: 23415111). In drug discovery, specific cysteine residues are targeted by covalent inhibitors to achieve high selectivity and prolonged pharmacodynamics, as seen in treatments for various cancers (Source: PubMed, PMID: 21814247). However, the inherent reactivity of cysteines across the proteome necessitates careful design to avoid off-target effects and potential immunogenicity (Source: PubMed, PMID: 27033577).
Covalent modification of the nucleophilic thiol group, typically via Michael addition with electrophilic warheads, to irreversibly or reversibly inhibit protein function (Source: PubMed, PMID: 21814247).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein cysteine residue (Cys).